Poland· PL-100505569
Vancomycin Neupharm
A j01xa01, a07aa09 product containing vancomycinum, registered in Poland by Neupharm Sp. z o.o..
Checked against URPL (Poland) on
Informational only — not a medical device.
The record
At a glance
URPL (Poland)- Active substance
- Vancomycinum
- Manufacturer
- Neupharm Sp. z o.o.
- Country
- Poland (PL)
- ATC code
- J01XA01, A07AA09
- ATC class
- J01XA01, A07AA09
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 1
- gtin05909991554682
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Vancomycinum in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaVANCOMYCIN APTAPHARMAApta Medica Internacional d.o.o., Ljubljana
- United KingdomVancocin 500mg powder for solution for infusion vialsFlynn Pharma Ltd
- FinlandNorimkoNRIM Limited
- BelgiumVamysin 500 mgTeva Pharma Belgium
- SwedenVancomycin Bioglan 500 mg Pulver till koncentrat till infusionsvätska, lösningBioglan AB
- IrelandVancocin 500 mg powder for concentrate for solution for infusion and powder for oral solutionFlynn Pharma Limited
- SwitzerlandVanco Labatec 500 mg, poudre pour solution à diluer pour perfusionLabatec Pharma SA
- SpainVANCOMICINA MIP 500 MG POLVO PARA SOLUCION PARA PERFUSION EFGMip Pharma Gmbh
Authorised across Europe · EMA
The same active substance is authorised in 29 EEA countries. Names it is sold under:
- Austria · Vancocin, Vancomycin Aptapharma
- Belgium · Vancomycine Fresenius Kabi, Vancomycine Sandoz
- Bulgaria · Vancocin Cp, Ванко-Вм
- Cyprus · Vanco, Vanco Sapiens
- Czechia · Cedepos, Edicin
- Germany · Vanco-Saar, Vancomycin "lederle"
- Denmark · Bactocin, Vancocin
- Estonia · Vancomycin Kabi, Vancosan
- Spain · Vancomicina Mip, Vancomicina Noridem
- Finland · Vancomycin Bioglan, Vancomycin Bioglan 500 Mg Pulver Till Koncentrat Till Infusionsvätska, Lösning
- France · Vancomycine Hikma, Vancomycine Kabi
- United Kingdom (Northern Ireland) · Vancocin, Vancocin Matrigel
- Greece · Lyovanco, Vancomycin Noridem
- Croatia · Edicin, Vancomicin Viatris
- Hungary · Vancocin, Vancomycin Aptapharma
- Ireland · Vancocin, Vancocin Matrigel
- Iceland · Vancomycin Fresenius Kabi, Vancomycin Hameln
- Italy · Levovanox, Maxivanil
- Lithuania · Vancomycin Ibe, Vancomycin Kabi
- Luxembourg · Vancomycin Enterocaps, Vancomycine
- Latvia · Vancomycin Kabi, Vancosan
- Malta · Cedepos, Vancomycin Aptapharma
- Netherlands · Vancocin Cp, Vancomycine Fresenius Kabi
- Norway · Vancomycin Fresenius Kabi, Vancomycin Hameln
- Portugal · Vancomicina Azevedos, Vancomicina Generis
- Romania · Cedepos, Vancomicină Aptapharma
- Sweden · Vancocin, Vancomycin Bioglan
- Slovenia · Edicin, Vancomycin Viatris
- Slovakia · Cedepos, Edicin
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/d8a745d0-3de4-4edd-ae61-06571b53dfc1 GET /v1/drugs/d8a745d0-3de4-4edd-ae61-06571b53dfc1?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Proszek do sporządzania koncentratu roztworu do infuzji",
"source": "urpl",
"strength": "500 mg",
"packaging": "05909991554682 ¦ Lz ¦ 158073\n10 fiol.",
"substance": "Vancomycinum 500 mg",
"common_name": "Vancomycinum",
"pl_product_id": "100505569",
"pozwolenie_nr": "339/24",
"auth_procedure": "IR",
"authorisation_validity": "2029-09-18"
}See everything about vancomycinum.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.